Chromosomal localization of human GRIM-19, a novel IFN-β and retinoic acid-activated regulator of cell death

Journal of Interferon and Cytokine Research

Volumn 20, Issue 7, 2000, Pages 661-665

  Chidambaram, Natesa V ^a   Angell, Jon E ^a   Ling, Wang ^a   Hofmann, Edward R ^a   Kalvakolanu, Dhananjaya V ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 19P; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL DEATH; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; DNA, ANTISENSE; FEMALE; GENES, TUMOR SUPPRESSOR; GENOMIC LIBRARY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-BETA; KARYOTYPING; TRETINOIN; TUMOR CELLS, CULTURED;

MAMMALIA; METAZOA;

EID: 0033910295     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000414844     Document Type: Article

References (22)

1. KORSMEYER, SJ. (1999). bcl-2 gene family and the regulation of programmed cell death. Cancer Res. 59, 1693s-1700s.
2. ASHKENAZI, A., and DIXIT, V.M. (1998). Death receptors: signaling and modulation. Science 281, 1305-1308.
3. THORNBERRY, N.A., and LAZEBNIK, Y. (1998). Caspases: enemies within. Science 281, 1312-1316.
4. KALVAKOLANU, D.V., and BORDEN, E.C. (1996). An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest. 14, 25-53.
5. HONG, W.K., and ITRI, L.M. (1994). Retinoids and human cancer. In: The Retinoids: Biology, Chemistry and Medicine. M.B. Sporn, A.B. Roberts, and D.S. Goodman (eds.) New York: Raven Press, pp. 597-630.
6. EVANS, T.R., and KAYE, S.B. (1999). Retinoids: present role and future potential. Br. J. Cancer 80, 1-8.
7. MOORE, D.M., KALVAKOLANU, D.V., LIPPMAN, S.M., KAVANAGH, J.J., HONG, W.K., BORDEN, E.G., PAREDES-ESPINOZA, M., and KRAKOFF, I.H. (1994). Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Semin. Hematol. 31, 31-37.
8. LINDNER, D.J., BORDEN, E.C., and KALVAKOLANU, D.V. (1997). Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo, Clin. Cancer Res. 3, 931-937.
9. HOFMANN, E.R., BOYANAPALLI, M., LINDNER, D.J., WEI- HUA, X., HASSEL, B.A., JAGUS, R., GUTIERREZ, P.L., and KALVAKOLANU, D.V. (1998). Thioredoxin reductase mediates the cell death effects of interferon-β and retinoic acid combination. Mol. Cell. Biol. 18, 6493-6504.
10. DEISS, L.P., and KIMCHI, A. (1991). A genetic tool used to identify thioredoxin as a mediator qf a growth inhibitory signal. Sci- ence 252, 117-120.
11. SKEHAN, P., STORENG, R., SCUDIERO, D., MONKS, A., McMAHON, J., VISTICA, D., WARREN, J.T., BOKESCH, H., KENNEY, S., and BOYD, M.R. (1990). New colorimetric cyto- toxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107-1112.
12. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., STRUHL, K. (1994). Current Protocols in Molecular Biology. New York: Wiley-Interscience.
13. HENG, H.H., SQUIRE, J., and TSUI, L.C. (1992). High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc. Natl. Acad. Sci, USA 89, 9509-9513.
14. HENG, H.H., and TSUI, L.C. (1993). Modes of DAPI banding and simultaneous in situ hybridization. Chromosoma 102, 325-332.
15. GAO, A.C., LOU, W., ICHIKAWA, T., DENMEADE, S.R., BARRETT, J.C., and ISAACS, J.T. (1999). Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p l3.1-13.2. Prostate 38, 46-54.
16. TANIGUCHI, T., LAMPHIER, M.S., and TANAKA, N. (1997). IRF1: the transcription factor linking interferon response and oncogenesis. Biochim. Biophys, Acta 1333, M9-M17.
17. HOLTSCHKE, T., LOHLER, J., KANNO, Y., FEHR, T., GIESE, N., ROSENBAUER, F., LOU, J., KNOBELOCH, K.P., GABRIELE, L., WARING, J., BACHMANN, M.F., ZINKERNAGEL, R.M., MORSE, H.C., OZATO, K., and HORAK, I. (1996). Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307-317.
18. HAO, S.X., and REN, R. (2000). Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder. Mol. Cell. Biol. 20, 1149-1161.
19. KUMAR, A., COMMANE, M., FLICKINGER, T.W., HORVATH, CM., and STARK, G.R. (1997). Defective TNF-alpha- induced apoptosis in Stat 1-null cells due to low constitutive levels of caspases. Science 278, 1630-1632.
20. KAPLAN, D.H., SHANKARAN, V., DIGHE, A.S., STOCKERT, E., AGUET, M., OLD, L.J., and SCHREIBER, R.D. (1998). Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561.
21. 2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 16, 998-1008.
22. INBAL, B., COHEN, O., POLAK-CHARCON, S., KOPOLOVIC, J., VADAI, E., EISENBACH, L., and KIMCHI, A. (1997). DAP kinase links the control of apoptosis to metastasis. Nature 390, 180-184.